The vaccine used for tamariki is a children’s version of the Pfizer vaccine, with a lower dose and smaller volume. The lower dose was chosen based on a trial which showed the lower dose was safe and had few side effects in this age group.
If a child has their second vaccination after they have turned 12, they should still complete their vaccination course with the paediatric formulation of the Pfizer vaccine.
Tamariki need two doses of the vaccine to be fully protected. It is recommend by The Ministry of Health that these are at least 8 weeks apart. The interval can be shortened to a minimum of 21 days if needed, for example if the tamaiti is starting significant immunosuppression treatment. Tamariki aged 5 to 11 are not eligible for AstraZeneca or booster vaccinations.